Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Cairn Homes lifts profit outlook as order book jumps

(Sharecast News) - Cairn Homes reported a drop in first-half revenues on the back of lower property sales, though a big increase in the order book has bolstered the outlook for the second half, prompting an upgrade to guidance for the full year. The Irish housebuilder now expects 2025 operating profits to be between €160m and €165m, compared with previous guidance of €160m. Revenues are tipped to come in at €945m, representing growth of around 10%.

The company also introduced 2026 guidance for the first time, pushing for further growth in both measures to €175m-180m and €1.02bn-1.05bn, respectively.

Revenues over the six months to 30 June fell to €284.5m, down from €366.1m the year before, as Cairn sold just 708 units, down from 893 units previously, while the average selling price remained steady at €387,000.

As a result, gross profits fell to €63.1m from €80.4m, though the gross margin improved to 22.2% from 22.0% due to operational efficiencies.

Despite the weaker results, the company's closed and forward order book stood at 4,092 homes by the end of the half, up 1,700 since the start of the year.

Looking forward, Cairn welcomed the significant policies, initiatives and legislative changes introduced by the Irish government this year, as it attempted to increase housing delivery. Meanwhile, mortgage market conditions "remain positive" amid falling interest rates and strong wage growth, it said.

"The Government has put in place a suite of policies which can, if efficiently implemented, make a material difference in the delivery of new homes in the years ahead. In response, we will continue to invest in our own construction activity to deliver even greater numbers of quality homes for our customers," said chief executive Michael Stanley.

Shares were up 2% in early deals in London at 190p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.